Moderna
FDA Changes Its Stance: A New Review of Moderna’s Flu Vaccine is on the Horizon!
The FDA recently announced it will review Moderna’s application for a new flu vaccine, specifically for adults aged 50 and ... Read more
Insights from Moderna’s President: What the FDA’s Decision on the Flu Vaccine Means for You
In August, the FDA assured Moderna it would review its application for a new flu vaccine. This promise was based ... Read more
Time’s Running Out, President Trump: Safeguard Your Groundbreaking Healthcare Legacy
In May 2020, President Donald J. Trump touted the development of mRNA COVID-19 vaccines as a remarkable achievement. Supporters claimed ... Read more
RFK Jr. Secures $500 Million Investment to Transform Vaccine Development
WASHINGTON (AP) — The Department of Health and Human Services is pulling funding for several vaccine projects aimed at fighting ... Read more
